These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 8017062)
1. [The antiviral activity of inhibitors of ADP ribosylation in experimental alpha- and bunyavirus infections]. Krasil'nikov II; Levshina EV; Belova RI; Starenchenko VV; Tsikarishvili GV; Katsalukha VV Vopr Virusol; 1994; 39(2):85-7. PubMed ID: 8017062 [TBL] [Abstract][Full Text] [Related]
2. [The effect of the peroxidation of ribamidil-containing liposomes on the results of chemotherapy in experimental viral infections]. Khamitov RA; Grabareva LP; Pshenichnov VA; Eres'kina OA Vopr Virusol; 1993; 38(1):21-4. PubMed ID: 8073740 [TBL] [Abstract][Full Text] [Related]
3. [An experimental study of ADP-ribosylation inhibitors as anti-influenza agents]. Vladimirov VG; Krasil'nikov II; Volgarev AP; Platonov VG Vopr Virusol; 1991; 36(4):293-5. PubMed ID: 1796583 [TBL] [Abstract][Full Text] [Related]
4. [Antiviral and immunostimulating effect of maleic anhydride copolymers in experimental neuroviral infections]. Davydova AA; Stotskaia LL; Berezina LK; Osipova LV; Barinskiĭ IF Vopr Virusol; 1986; 31(5):595-8. PubMed ID: 3099477 [TBL] [Abstract][Full Text] [Related]
5. [The use of methisazone for preventing viral encephalitis and encephalomyelitis in an experiment in white mice]. Tarasenko AB; Votiakov VI; Mishaeva NP; Zgirovskaia AA; Zubovich IK Vopr Virusol; 1990; 35(2):158-60. PubMed ID: 2389571 [No Abstract] [Full Text] [Related]
6. [The antiviral efficacy of ribamidil in an experimental infection of animals with the Venezuelan equine encephalomyelitis virus]. Markin VA; Pashanin IuG; Markov VI; Androshchuk IA; Pshenichnov VA Vopr Virusol; 1990; 35(3):237-40. PubMed ID: 2219858 [TBL] [Abstract][Full Text] [Related]
7. [Experimental and clinicolaboratory evaluation of complex therapy efficacy in arboviral infections]. Romantsov MG; Galimzianov KhM; Lokteva OM; Kovalenko AL; Stepanov AV Antibiot Khimioter; 2012; 57(7-8):12-22. PubMed ID: 23350190 [TBL] [Abstract][Full Text] [Related]
8. [Inhibitors of ADP ribosylation as antiviral agents: an experimental study in a model of HIV infection]. Krasil'nikov II; Kalnina LB; Korneeva MN; Nosik DN; Zlobin AIu; Vladimirov VG; L'vov DK Vopr Virusol; 1991; 36(3):216-8. PubMed ID: 1832508 [TBL] [Abstract][Full Text] [Related]
9. The antiviral activity of acridines in eastern equine encephalomyelitis, Rift Valley fever and psittacosis in mice, and lymphogranuloma venereum in chick-embryos. GRENNHALGH N; HULL R; HURST EW Br J Pharmacol Chemother; 1956 Jun; 11(2):220-4. PubMed ID: 13329343 [No Abstract] [Full Text] [Related]
10. [The efficacy of the therapeutic and prophylactic actions of immunomodulators in experimental infection due to the causative agent of Venezuelan equine encephalomyelitis]. Bulychev LE; Sergeeva AN; Ryzhikov AB; Kotliarov LA; Poryvaev VD; Pliasunov IV Antibiot Khimioter; 1995 May; 40(5):28-31. PubMed ID: 8534176 [TBL] [Abstract][Full Text] [Related]
11. Novel indole-2-carboxamide compounds are potent broad-spectrum antivirals active against western equine encephalitis virus in vivo. Delekta PC; Dobry CJ; Sindac JA; Barraza SJ; Blakely PK; Xiang J; Kirchhoff PD; Keep RF; Irani DN; Larsen SD; Miller DJ J Virol; 2014 Oct; 88(19):11199-214. PubMed ID: 25031353 [TBL] [Abstract][Full Text] [Related]
12. Antibody and interleukin-12 treatment in murine models of encephalitogenic flavivirus (St. Louis encephalitis, tick-borne encephalitis) and alphavirus (Venezuelan equine encephalitis) infection. Phillpotts RJ; Jones LD; Lukaszewski RA; Lawrie C; Brooks TJ J Interferon Cytokine Res; 2003 Jan; 23(1):47-50. PubMed ID: 12639298 [TBL] [Abstract][Full Text] [Related]
13. Melatonin, minocycline and ascorbic acid reduce oxidative stress and viral titers and increase survival rate in experimental Venezuelan equine encephalitis. Valero N; Mosquera J; Alcocer S; Bonilla E; Salazar J; Álvarez-Mon M Brain Res; 2015 Oct; 1622():368-76. PubMed ID: 26168898 [TBL] [Abstract][Full Text] [Related]
14. Cross-protective immunity between equine encephalomyelitis viruses in equids. Walton TE; Jochim MM; Barber TL; Thompson LH Am J Vet Res; 1989 Sep; 50(9):1442-6. PubMed ID: 2552875 [TBL] [Abstract][Full Text] [Related]
15. [Effect of immunosuppressants on the enhanced sensitivity of white mice to the eastern equine encephalitis virus]. Solianik RG; Anosova GV; Fedorov IuV Virologie; 1985; 36(1):41-6. PubMed ID: 2988194 [TBL] [Abstract][Full Text] [Related]
16. [Effect of virulent and anttenuated variants of viruses of American equine encephalomyelitis on the mitotic activity of the cells]. Baum EL; Miriutova TL Vopr Virusol; 1978; (1):81-5. PubMed ID: 645059 [TBL] [Abstract][Full Text] [Related]
17. Enhanced efficacy of liposome-encapsulated ribavirin against Rift Valley fever virus infection in mice. Kende M; Alving CR; Rill WL; Swartz GM; Canonico PG Antimicrob Agents Chemother; 1985 Jun; 27(6):903-7. PubMed ID: 4026264 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of trivalent inactivated encephalomyelitis virus vaccine in horses. Barber TL; Walton TE; Lewis KJ Am J Vet Res; 1978 Apr; 39(4):621-5. PubMed ID: 646197 [TBL] [Abstract][Full Text] [Related]
19. [The efficacy of immobilized liposomal preparations of ribamidil in experimental Rift Valley fever]. Grabareva LP; Khamitov RA; Pshenichnov VA Vopr Virusol; 1991; 36(6):512-4. PubMed ID: 1785190 [No Abstract] [Full Text] [Related]
20. [Development of methodology for predictably significant evaluation of the protective efficacy of antiviral agents]. Markin VA Vopr Virusol; 2012; 57(2):14-9. PubMed ID: 22834141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]